Centese

Based in Omaha, Nebraska, Centese is a medical device company that develops intelligent surgical drainage systems to address clinical challenges in cardiothoracic procedures. The organization's flagship product, Thoraguard, functions as an automated chest tube monitor that improves fluid management accuracy for patients recovering from complex surgeries. By replacing traditional analog methods with digital monitoring technology, the system reduces post-operative complications, shortens hospital stays, and lowers overall healthcare costs. Following the commercial launch and scaling of the Thoraguard platform, the enterprise has generated millions of dollars in revenue through direct sales to hospitals and surgical centers. Centese is supported by a network of prominent healthcare advisors and investors, featuring recognizable names such as Theranova, Ehrenberg Chesler, the Nebraska Heart Institute, and Medtech Venture Partners. The medical technology company was founded by Evan Luxon and Randy Preston.